EXACT SCIENCES CORP Quarterly Income Tax Expense (Benefit) in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Exact Sciences Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q3 2024.
  • Exact Sciences Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $808K, a 224% increase year-over-year.
  • Exact Sciences Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $3.47M, a 317% increase year-over-year.
  • Exact Sciences Corp annual Income Tax Expense (Benefit) for 2023 was $2.4M.
  • Exact Sciences Corp annual Income Tax Expense (Benefit) for 2022 was -$9.06M, a 96.3% increase from 2021.
  • Exact Sciences Corp annual Income Tax Expense (Benefit) for 2021 was -$247M, a 4423% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.47M $808K +$559K +224% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $2.91M $1.46M +$356K +32.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $2.55M $1.81M +$149K +8.99% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.4M -$610K +$1.57M +72% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $831K $249K +$3.37M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$2.53M $1.11M +$2.86M Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 -$5.39M $1.66M +$3.67M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$9.06M -$2.18M +$2.06M +48.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 -$11.1M -$3.12M +$742K +19.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$11.9M -$1.75M -$5.78M -144% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$6.09M -$2.02M +$241M +99.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$247M -$4.24M -$4.08M -2487% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-22
Q3 2021 -$243M -$3.86M -$1.11M -40.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$242M $4.03M +$4.33M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$246M -$243M -$241M -10754% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-26
Q4 2020 -$5.46M -$164K +$184M +99.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-22
Q3 2020 -$190M -$2.75M -$3.44M -503% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-22
Q2 2020 -$186M -$305K +$138K +31.2% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-22
Q1 2020 -$187M -$2.24M -$1.77M -376% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-22
Q4 2019 -$185M -$185M -$185M -2637643% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-16
Q3 2019 -$223K $683K +$656K +2430% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-16
Q2 2019 -$879K -$443K -$442K Apr 1, 2019 Jun 30, 2019 10-K 2021-02-16
Q1 2019 -$437K -$470K -$529K -897% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-16
Q4 2018 $92K $7K -$37K -84.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 $129K $27K +$258K Jul 1, 2018 Sep 30, 2018 10-K 2020-02-21
Q2 2018 -$129K -$1K* -$35K Apr 1, 2018 Jun 30, 2018 10-K 2020-02-21
Q1 2018 -$94K $59K -$16K -21.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-21
Q4 2017 -$78K $44K Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 -$231K Jul 1, 2017 Sep 30, 2017 10-K 2019-02-21
Q2 2017 $34K Apr 1, 2017 Jun 30, 2017 10-K 2018-02-22
Q1 2017 $75K Jan 1, 2017 Mar 31, 2017 10-K 2018-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.